D29.21 — Benign neoplasm of right testis
Is D29.21 billable?
Yes — D29.21 is billable for FY2027. D29.21 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D29.21 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D29.21 at a glance
| Code | D29.21 |
|---|---|
| Description | Benign neoplasm of right testis |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D29.21 group to?
D29.21 sits in MDC 12 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 729Other Male Reproductive System Diagnoses with CC/MCCmedical
- 730Other Male Reproductive System Diagnoses without CC/MCCmedical
How is D29.21 listed in the Alphabetic Index?
The Alphabetic Index lists these routes under D29.2, the nearest indexed parent of D29.21. Use them to find the family, then select the specific code.
- Leydig-Sertoli cell tumor › unspecified site › male
- Teratoma › testis › adult, benign, cystic, differentiated type or mature (solid)
- Leydig cell › tumor › benign › unspecified site › male
Use additional code — inherited from D29.2
Report an additional code alongside D29.21 to fully describe the condition. D29.21 is sequenced first.
- code to identify any functional activity.
How long has D29.21 existed?
D29.21 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.